Bioengineered production of glycosaminoglycans and their analogues  

在线阅读下载全文

作  者:Weihua Jin Fuming Zhang Robert J.Linhardt 

机构地区:[1]College of Biotechnology and Bioengineering,Zhejiang University of Technology,Hangzhou 310014,China [2]Department of Chemical and Biological Engineering,Center for Biotechnology and Interdisciplinary Studies,Rensselaer Polytechnic Institute,Troy,NY 12180,USA [3]Department of Biological Science,Departments of Chemistry and Chemical Biology and Biomedical Engineering,Center for Biotechnology and Interdisciplinary Studies,Rensselaer Polytechnic Institute,Troy,NY 12180,USA

出  处:《Systems Microbiology and Biomanufacturing》2021年第2期123-130,共8页系统微生物学与生物制造(英文)

基  金:This study was supported by China Scholarship Council(W.J.);the National Institutes of Health(DK111958 and CA231074)(F.Z.and R.J.L.).

摘  要:Glycosaminoglycans(GAGs)are a class of linear polysaccharides,consisting of alternating disaccharide sequences of uronic acid and hexosamines(or galactose)with and without sulfation.They can interact with various proteins,such as growth factors,receptors and cell adhesion molecules,endowing these with various biological and pharmacological activi-ties.Such activities make GAGs useful in health care products and medicines.Currently,all GAGs,with the exception of hyaluronan,are produced by extraction from animal tissues.However,limited availability,poor control of animal tissues,impurities,viruses,prions,endotoxins,contamination and other problems have increased the interest in new approaches for GAG production.These new approaches include GAGs production by chemical synthesis,chemoenzymatic synthesis and metabolic engineering.One chemically synthesized heparin pentasaccharide,fondaparinux sodium,is in clinical use.Mostly,hyaluronan today is prepared by microbial fermentation,largely replacing hyaluronan from rooster comb.The recent gram scale chemoenzymatic synthesis of a heparin dodecasaccharide suggests its potential to replace currently used animal-sourced low molecular weight heparin(LMWH).Despite these considerable successes,such high-tech approaches still cannot meet worldwide demands for GAGs.This review gives a brief introduction on the manufacturing of unfractionated and low molecular weight heparins,the chemical synthesis and chemoenzymatic synthesis of GAGs and focuses on the progress in the bioengineered preparation of GAGs,particularly heparin.

关 键 词:GLYCOSAMINOGLYCANS Metabolic engineering Chemoenzymatic synthesis HEPARIN 

分 类 号:O62[理学—有机化学]

 

参考文献:

正在载入数据...

 

二级参考文献:

正在载入数据...

 

耦合文献:

正在载入数据...

 

引证文献:

正在载入数据...

 

二级引证文献:

正在载入数据...

 

同被引文献:

正在载入数据...

 

相关期刊文献:

正在载入数据...

相关的主题
相关的作者对象
相关的机构对象